{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-03",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Ineligible",
      "product_code": "PHP",
      "openfda": {
        "pma_number": [
          "P130001",
          "P250029",
          "P230043",
          "P230009",
          "P130017"
        ],
        "registration_number": [
          "3012090384",
          "1938173",
          "3008256118",
          "3013841562",
          "3011397539",
          "3015728010",
          "2435505",
          "1550222",
          "3032518803",
          "9681753",
          "2134944"
        ],
        "fei_number": [
          "3012090384",
          "1938173",
          "3008256118",
          "3013841562",
          "3011397539",
          "3015728010",
          "3000303338",
          "1550222",
          "1000119795",
          "3004058281",
          "3032518803"
        ]
      },
      "review_panel": "PA",
      "medical_specialty": "",
      "device_name": "System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Unknown",
      "device_class": "3",
      "definition": "The colorectal neoplasia DNA methylation and hemoglobin detection system is a qualitative, non-invasive device used to screen for the detection of methylation of specific DNA markers associated with colorectal cancer and for the presence of occult hemoglobin in human specimens, including stool, blood, urine, and buccal swabs.  It is intended as an aid in the detection of colorectal cancer or advanced adenomas in conjunction with diagnostic colonoscopy.  It is indicated for use in adults 50 years or older, who are typical average-risk candidates for colorectal cancer (CRC) screening.",
      "regulation_number": "",
      "implant_flag": "N",
      "submission_type_id": "2"
    }
  ]
}